NCT00437372 2025-05-02Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer PatientsThomas Jefferson UniversityPhase 1 Completed39 enrolled
NCT00906360 2013-07-02Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckNational Cancer Institute (NCI)Phase 1 Terminated36 enrolled